These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current standard and investigational approaches to the management of hormone-refractory prostate cancer. Mendiratta P; Armstrong AJ; George DJ Rev Urol; 2007; 9 Suppl 1(Suppl 1):S9-S19. PubMed ID: 17387372 [TBL] [Abstract][Full Text] [Related]
3. Update in the management of patients with hormone-refractory prostate cancer. Moore CN; George DJ Curr Opin Urol; 2005 May; 15(3):157-62. PubMed ID: 15815191 [TBL] [Abstract][Full Text] [Related]
4. Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma. Chang SS; Benson MC; Campbell SC; Crook J; Dreicer R; Evans CP; Hall MC; Higano C; Kelly WK; Sartor O; Smith JA; Cancer; 2005 Jan; 103(1):11-21. PubMed ID: 15558815 [TBL] [Abstract][Full Text] [Related]
5. Southwest Oncology Group studies in hormone-refractory prostate cancer. Hussain MH; Blumenstein B; Eisenberger M; Crawford ED Semin Oncol; 1996 Dec; 23(6 Suppl 14):24-7. PubMed ID: 8996581 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy for the treatment of hormone-refractory prostate cancer. Chowdhury S; Burbridge S; Harper PG Int J Clin Pract; 2007 Dec; 61(12):2064-70. PubMed ID: 17956560 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic chemotherapy for prostate cancer: Who and when? Moss RA; Petrylak DP Curr Treat Options Oncol; 2006 Sep; 7(5):370-7. PubMed ID: 16904054 [TBL] [Abstract][Full Text] [Related]
8. [Options of Chemotherapy in the Treatment of Prostate Cancer]. Richter I; Dvořák J; Bartoš J Klin Onkol; 2017; 30(1):28-33. PubMed ID: 28185462 [TBL] [Abstract][Full Text] [Related]
16. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy. Berry W; Eisenberger M Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869 [TBL] [Abstract][Full Text] [Related]
17. Hormone-refractory prostate cancer: where are we going? Di Lorenzo G; Autorino R; Figg WD; De Placido S Drugs; 2007; 67(8):1109-24. PubMed ID: 17521214 [TBL] [Abstract][Full Text] [Related]
18. The evolving role of chemotherapy in androgen-independent (hormone-refractory) prostate cancer. Berry WR Urology; 2005 Jun; 65(6 Suppl):2-7. PubMed ID: 15939076 [TBL] [Abstract][Full Text] [Related]
19. An interdisciplinary approach to treating prostate cancer. Kibel AS Urology; 2005 Jun; 65(6 Suppl):13-8. PubMed ID: 15939078 [TBL] [Abstract][Full Text] [Related]